Vaccines

>

Latest News

FDA clears investigational NDA for VAX-31 to prevent invasive pneumococcal disease | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.
FDA clears investigational NDA for VAX-31 to prevent invasive pneumococcal disease

November 12th 2024

The initiation of a phase 2 study of the investigational 31-valent pneumococcal conjugate vaccine is expected by the end of January 2025.

MenACWY program associated with reduced invasive meningococcal disease among adolescentsLatest revision | Image Credit: © Generative AI - © Generative AI - stock.adobe.com.
MenACWY program associated with reduced invasive meningococcal disease among adolescents

November 7th 2024

Typical RSV vaccine uptake could lead to few pediatric ICU encounters | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com.
Typical RSV vaccine uptake could lead to fewer pediatric ICU encounters

October 28th 2024

Office preparation for fall vaccine administration: Are you ready? | Image Credit: © REDPIXEL - © REDPIXEL - stock.adobe.com.
Office preparation for fall vaccine administration: Are you ready?

October 24th 2024

Pneumococcal conjugate vaccine: A glimpse into current recommendationsLatest revision | Image Credit: © AdobeStock_74430853 - © AdobeStock_74430853 - stock.adobe.com.
Pneumococcal conjugate vaccine: A glimpse into current recommendations

October 24th 2024

<1
...
56789
© 2024 MJH Life Sciences

All rights reserved.